Advanced Nutrition
Course No. FN – 501
Chapter No. 3
Lipids
Assignment submitted to
Rehana Begum
Assistant Professor
Department of Food and Nutrition Science
College of Home Economics, Azimpur, Dhaka.
1
Maesha Musarrat (Lipids)
Submitted by
Serial No.
Name of the Student
Class roll
1
Maesha Musarrat
2336
2
Sharmin Akter Mina
2337
3
Sadia Rahman Kana
2338
4
Sadia Nusrat Bushra
2339
5
Farhana Yeasmin
2340
2
Maesha Musarrat (Lipids)
Contents
❖ Lipids
General Properties
Classification of lipids
Lipids are of great importance to the body
❖ Fatty acids
General properties
Types of fatty acids
❖ Essential fatty acids
Omega-3 Fatty acid (2014, 2012, 2011)
Sources of Omega 3 Fatty acids
Functions of omega 3 fatty acids
Omega-6 fatty acid (2014, 2012, 2011)
Dietary sources of omega-6 fatty acids include
Functions of omega 6 fatty acids
Omega-6/Omega-3 ratio (2011, 2009, 2008)
❖ Level of different types of lipid in the human body
❖ Cholesterol
Structure of Cholesterol:
The Pathways of Cholesterol Metabolism (2014, 2011, 2008)
▪ Endogenous pathway
▪ Exogenous pathway
▪ Reverse cholesterol pathway
Diseases related to Cholesterol metabolism (2014, 2011)
▪ Hypercholesterolemia
▪ Hypocholesterolemia
3
Maesha Musarrat (Lipids)
❖ Membrane lipid(2008, 2010)
Types of membrane lipids
Functions of membrane lipids
❖ Phospholipids(2012)
Location
Amphipathic nature of phospholipids (2010)
Classification of Phospholipids (2010)
Functions of Phospholipids
❖ Ecosanoids (2014, 2013, 2009)
E osa oids are Lo al Hor o es
Major pathways of eicosanoids metabolism (2012)
▪ (Role of Cyclooxygenase) 2008
▪ (Role of Lipooxygenase) 2008
❖ Enterohepatic circulation of Bile acids and Bile salts (2010)
❖ The rate limiting step in bile acid synthesis (2012)
❖ Prostaglandins
Structure of Prostaglandins
Synthesis of Prostaglandins
Biochemical Functions of Prostaglandins (2010)
❖ NSAIDs (2010)
Classification of NSAIDs
Most Common Types of NSAIDs
Other Forms of NSAIDs
Medical uses of NSAIDs
Mechanism of action of NSAIDs
Antipyretic activity of NSAIDs
Risks associated with using NSAIDs
4
Maesha Musarrat (Lipids)
❖ COX-1 and COX-2 (2014, 2009)
❖ Diets rich in Marine lipids (2012)
Decrease cholesterol level
Decrease prostaglandin level
Decrease leukotrine level
❖ Synthetic Lipid (2013, 2012, 2010)
Examples of synthetic lipid
Synthetic Phospholipid derivatives
Functions of synthetic lipids
❖ The occurrence of main lipids in the human body (2014)
❖ HDL is more important than VLDL (2009)
5
Maesha Musarrat (Lipids)
❖ Lipids
In biology, lipids comprise a group of naturally occurring molecules that include
fats, waxes, sterols, fat-soluble vitamins (such as vitamins A, D, E, and K),
monoglycerides, diglycerides, triglycerides, phospholipids, and others.
The term lipid was 1st used by the German biochemist Bloor in 1943 for a major
class of tissue components and foodstuffs.
Origin
General Properties
•
•
•
•
•
•
Heterogenous group of compounds,
greasy/oily organic substances,
insoluble in water,
soluble in organic solvents (alcohol, benzene, chloroform, ether etc),
hydrophobic in nature,
Unlike the polysaccharides, proteins and nucleic acids, lipids are not
polymers. Further, lipids are mostly small molecules.
6
Maesha Musarrat (Lipids)
Classification of lipids
Simple Lipids:
Esters of fatty
acids with
alcohols
Complex lipids:
Esters of fatty
acids with
alcohols
containing
additional
groups such as
phosphate,
nitrogen base,
CHO, protein
etc.
(a) Fats and oils (triacylglycerols):
• esters of glycerol and fatty acids: e.g. triacylglycerols
• Differece between fat and oil is physical. Oil is liquid
while fat is solid at room temperature.
(b)Waxes:
• esters of long-chain fatty acids and alcohols other than
glycerols
• Ceityl alcohol is most commonly used
(a) Phosphplipids:
contain phosphoric acid and frequently a nitrogenous base. This
is in addition to alcohol and fatty acids.
I. Glycerophopholipids: contain glycerol as the alcohol e.g.
lecithin, cephalin
II. Sphingophosphplipids: contain sphingosine as the
alcohol e.g.
sphingomyelin
(b) Glycolipids / Glycosphingolipids:
• Contain a fatty acid, carbohydrate, sphingosine and
nitrogenous base.
• Glycerol and phosphate are absent e.g. cerebroside,
gangliosides.
(c) Lipoproteins:
• Macromoleculer complexes of lipids with proteins.
• e.g. LDL, VLDL, chylomicrons, HDL etc.
(d) Other complex lipids:
Sulpholipids, aminolipids and lipopolysaccharides come under
this
7
Maesha Musarrat (Lipids)
Derived lipids
Miscelleaneous
lipids
Neutral lipids
• These are the derivatives of hydrolysis of simple and
complex lipids which possess the characteristics of lipids.
• These include:
-Lipid soluble vitamins
-Steroid hormones
-Hydrocarbons
-Ketone bodies
-Mono and diacylglycerol ,etc
• A large number of compounds possess characteristics of
lipids,such compounds come under this category
• Example:carotenoids,squalene,hydrocarbons like
pentacosone and terpenes etc.
• These are the lipids which are uncharged and are
reffered ro as neutral lipids.
• These are mono, di and triacylglycerols, cholesterol and
cholesterol esters.
Lipids are of great importance to the body
Together with carbohydrates and proteins lipids constitute the principal
structural materials of living cells
Concentrated storage form of energy
Serve as an insulating material in the subcutaneous tissues and around
certain organs and give shape and smooth appearance to the body.
Serve as efficient source of energy (triacylglycerols) which is stored in the
adipose tissue
Lipids combined with proteins (lipoproteins) are important constituents of
the cell membranes (which regulate the membrane permeability) and
mitochondria of the cell.
Lipids are important as cellular metabolic regulators (steroid hormones and
prostaglandins).
They serve as a source of fat soluble vitamins (A, D, E & K)
8
Maesha Musarrat (Lipids)
Lipids are components of some enzyme systems.
Layers of fat in the subcutaneous layer, provides insulation and protection
from cold. Body temperature maintenance is done by brown fat.
❖ Fatty acids
A fatty acid is a carboxylic acid consisting of a long, straight and unbranched
hydrocarbon (aliphatic) chain and a terminal carboxyl group especially any of
those occurring as esters in fats and oils.
General properties
• Most naturally occurring fatty acids have an unbranched chain of an even
number of carbon atoms, from 14 to 20.
• Fatty acids are usually derived from triglycerides or phospholipids.
• Fatty acids are important dietary sources of fuel for animals because, when
metabolized, they yield large quantities of ATP. Many cell types can use
either glucose or fatty acids for this purpose.
• Long-chain fatty acids cannot cross the blood–brain barrier (BBB) and so
cannot be used as fuel by the cells of the central nervous system; however,
free short chain fatty acids and medium-chain fatty acids can cross the BBB,
in addition to glucose and ketone bodies.
• Solubility:
Longer chains: more hydrophobic, less soluble.
Double bonds increase solubility.
• Melting points:
Depend on chain length and saturation. Double bonds lead chain
disorder and low melting temperature.
Unsaturated FAs are solids at Room Temperature.
9
Maesha Musarrat (Lipids)
Types of fatty acids
According to the Length of the hydrocarbon Chain; fatty acids are of 4 types:
I.
Short-chain Fatty Acid
Short-chain fatty acids (SCFAs), also referred to as volatile fatty acids
(VFAs), are fatty acids with two to six carbon atoms. Free SCFAs can cross
the blood-brain barrier via monocarboxylate transporters.
II.
Medium chain fatty acids
Medium-chain fatty acids (MCFA) are fatty acids with aliphatic tails of 8 to
14 carbons.
III.
Long-chain fatty acids
Long-chain fatty acids (LCFA) are fatty acids with aliphatic tails of 16 to 20
carbons.
IV.
Very long chain fatty acid
A very long chain fatty acid (VLCFA) is a fatty acid with 22 or more carbons.
According to the degree of unsaturation fatty acids are of two types:
10
Maesha Musarrat (Lipids)
Saturated
Fatty Acid
Saturated fatty acids do not contain double bonds.
e.g. Capric acid, Lauric acid, Myristic acid etc.
Unsaturated fatty acids contain one or more double bonds
Unsaturated
Fatty Acid
Monounsaturated
Fatty Acid
•
•
•
Polyunsaturated
Fatty Acid
•
Fatty acids with one double bond are
monounsaturated (MUFA)
e.g. Palmitoleaic acid, Oleic acid
Fatty acids with 2 or more double bonds are
collectivelv known as polyunsaturated fatty
acids (PUFA).
e.g. Linoleic acid, Linolenic acid, Arachidonic
acid
11
Maesha Musarrat (Lipids)
❖ Essential fatty acids
Essential fatty acids, or EFAs, are fatty acids that humans and other animals must
ingest because the body requires them for good health but cannot synthesize
them. Those not essential are non-essential fatty acids. Chemically, EFAs are
polyunsaturated fatty acids, namelylinoleic acid &
Iinolenic acid
Arachidonic acid becomes essential if its precursor linoleic acid is not provided in
the diet in sufficient amounts.
The structures of EFA are given in the following table:
Omega-3 Fatty acid (2014, 2012, 2011)
Omega-3 fatty acids—also called ω-3 fatty acids or n-3 fatty acids are
polyunsaturated fatty acids (PUFAs) with a double bond (C=C) at the third carbon
atom from the end of the carbon chain. The fatty acids have two ends, the
carboxylic acid (-COOH) end, which is considered the beginning of the chain, thus
"alpha", and the methyl (-CH3) end, which is considered the "tail" of the chain,
thus "omega"; the double bond is at omega minus 3 (not dash 3). One way in
which a fatty acid is named is determined by the location of the first double bond,
counted from the methyl end, that is, the o ega ω-) or the n- end. However, the
standard (IUPAC) chemical nomenclature system starts from the carbonyl end.
12
Maesha Musarrat (Lipids)
The three types of omega-3 fatty acids involved in human physiology are αlinolenic acid (ALA) (found in plant oils), eicosapentaenoic acid (EPA), and
docosahexaenoic acid (DHA) (both commonly found in marine oils).
ALA o tai s
ar o ato s, hereas EPA a d DHA are o sidered lo g- hai
(LC) omega-3s because EPA contains 20 carbons and DHA contains 22.
13
Maesha Musarrat (Lipids)
Sources of Omega 3 Fatty acids
➢ Alpha-linolenic acid (ALA) is a type of Omega 3 fat found in plant foods
which cannot be manufactured by the human body. Once consumed, ALAs
can be converted into eicosapentaenoic acid (EPA) and docosahexaenoic
acid (DHA) but the conversion (which occurs primarily in the liver) is very
limited, with reported rates of less than 15%. EPAs and DHAs are also
typically found in seafood.
➢ ALA is present in plant oils, such as flaxseed, soybean, and canola oils . Chia
seeds and black walnuts also contain ALA.
➢ DHA and EPA are present in fish, fish oils, and krill oils, but they are
originally synthesized by microalgae, not by the fish. When fish consume
phytoplankton that consumed microalgae, they accumulate the omega-3s
in their tissues.
➢ The omega-3 content of fish varies widely. Cold-water fatty fish, such as
salmon, mackerel, tuna, herring, and sardines, contain high amounts of
14
Maesha Musarrat (Lipids)
long chain omega-3s ( EPA & DPA), whereas fish with a lower fat content—
such as bass, tilapia and cod—as well as shellfish contain lower levels.
➢ The omega-3 content of fish also depends on the composition of the food
that the fish consumes. Farmed fish usually have higher levels of EPA and
DHA than wild-caught fish, but it depends on the food they are fed. An
analysis of the fatty acid composition of farm-raised Atlantic salmon from
Scotland showed that the EPA and DHA content significantly decreased
between 2006 and 2015 due to the replacement of traditional marine
ingredients in fish feed with other ingredients.
➢ Beef is very low in omega-3s, but beef from grass-fed cows contains
somewhat higher levels of omega-3s, mainly as ALA, than that from grainfed cows.
➢ Some foods, such as certain brands of eggs, yogurt, juices, milk, and soy
beverages, are fortified with DHA and other omega-3s. Since 2002,
manufacturers have added DHA and arachidonic acid (the two most
prevalent LC PUFAs in the brain) to most infant formulas available in the
United States.
Source:
https://ods.od.nih.gov/factsheets/Omega3FattyAcidsHealthProfessional/#e
n3
Functions of omega 3 fatty acids
Cardiovascular disease (CVD) and CVD risk factors
Higher dietary or plasma levels of omega-3s are associated with a lower risk of
heart failure, coronary disease, and fatal coronary heart disease
Recommendations from the Dietary Guidelines for Americans: The 2015–2020
Dietary Guidelines for Americans states that eating patterns that include seafood
are associated with reduced risk of CVD. In addition, consuming about 8 ounces
per week of a variety of seafood that provides about 250 mg per day EPA and
DHA is associated with fewer cardiac deaths in both healthy individuals and those
with preexisting CVD.
15
Maesha Musarrat (Lipids)
Infant health and neurodevelopment
High concentrations of DHA are present in the cellular membranes of the brain
and retina, and DHA is important for fetal growth and development. The
accumulation of DHA in the retina is complete by birth, whereas accumulation in
the brain continues throughout the first 2 years after birth. Recommendations
from the Dietary Guidelines for Americans: The 2015–2020 Dietary Guidelines for
Americans states that women who are pregnant or breastfeeding should consume
8–12 ounces of seafood per week, choosing from varieties that are higher in EPA
and DHA and lower in methyl mercury, such as salmon, herring, sardines, and
trout. The American Academy of Pediatrics has similar advice for breastfeeding
women, recommending intakes of 200–300 mg DHA per day by consuming one to
two servings of fish per week to guarantee a sufficient amount of DHA in breast
milk.
Cancer prevention
Researchers have hypothesized that higher intakes of omega-3s from either foods
or supplements might reduce the risk of cancer due to their anti-inflammatory
effects and potential to inhibit cell growth factors.
Alzhei er’s disease, de e tia, a d cog itive fu ctio
Diets high in DHA are associated with a reduced risk of cognitive decline,
Alzhei er’s disease, a d de e tia. Be ause DHA is a esse tial o po e t of
cellular membrane phospholipids in the brain might protect cognitive function by
helping to maintain neuronal function and cell- membrane integrity within the
brain.
Age-Related Macular Degeneration (AMD)
AMD is a major cause of vision loss among older adults. In most cases, severe
vision loss is associated with advanced AMD, which consists of either central
geographic atrophy (dry AMD, the most common form) or neovascular AMD (wet
AMD . Based o DHA’s prese e as a stru tural lipid i reti al ellular e ra es
and the beneficial effects of EPA-derived eicosanoids on retinal inflammation,
neovascularization, and cell survival, researchers have suggested that these LC
16
Maesha Musarrat (Lipids)
omega-3s have cytoprotective effects in the retina that may help prevent the
development or progression of AMD.
Rheumatoid arthritis
Rheumatoid arthritis (RA) is an autoimmune disease characterized by chronic
inflammation of the joints. Its symptoms include pain, swelling, stiffness, and
functional impairments. RA is typically treated with nonsteroidal
antiinflammatory drugs (NSAIDs), corticosteroids, and disease-modifying
antirheumatic drugs. Due to their antiinflammatory effects, some scientists
hypothesize that LC omega- s redu e so e of the s pto s of RA a d patie ts’
reliance on NSAIDs and corticosteroids.
Other conditions
The benefits of omega-3 supplementation are being investigated for several other
conditions, including depression, inflammatory bowel disease, attention- deficit/
hyperactivity disorder (ADHD), childhood allergies, and cystic fibrosis.
Omega-6 fatty acid (2014, 2012, 2011)
Omega-6 fatty acids—also called ω-6 fatty acids or n-6 fatty acids are
polyunsaturated fatty acids (PUFAs), have their first double bond (C=C) at the 6th
carbon atom from the methyl (-CH3) end of the carbon chain, which is considered
the "tail" of the chain, thus "omega";
17
Maesha Musarrat (Lipids)
Omega-6 fatty acids help reduce inflammation, and some omega-6 fatty acids
tend to promote inflammation. In fact, some studies suggest that elevated intakes
of omega-6 fatty acids may play a role in complex regional pain syndrome. There
are several different types of omega-6 fatty acids, and not all promote
inflammation. Most omega-6 fatty acids in the diet come from vegetable oils,
such as linoleic acid (LA), Linoleic acid is converted to gamma-linolenic acid (GLA)
in the body. It can then break down further to arachidonic acid (AA).
GLA is found in several plant-based oils, including evening primrose oil (EPO),
borage oil, and black currant seed oil. GLA may actually reduce inflammation.
Much of the GLA taken as a supplement is converted to a substance called DGLA
that fights inflammation. Having enough of certain nutrients in the body
(including magnesium, zinc, and vitamins C, B3, and B6) helps promote the
conversion of GLA to DGLA.
18
Maesha Musarrat (Lipids)
Dietary sources of omega-6 fatty acids include:
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
poultry
eggs
nuts
cereals
durum wheat
whole-grain breads
most vegetable oils
grape seed oil
evening primrose oil
borage oil
blackcurrant seed oil
flax/linseed oil
rapeseed or canola oil
hemp oil
soybean oil
cottonseed oil
sunflower seed oil
corn oil
safflower oil
pumpkin seeds
acai berry
cashews
pecans
pine nuts
walnuts
spirulina
19
Maesha Musarrat (Lipids)
Functions of omega 6 fatty acids
Diabetic neuropathy
Some studies show that taking gamma linolenic acid (GLA) for 6 months or more
may reduce symptoms of nerve pain in people with diabetic neuropathy. People
who have good blood sugar control may find GLA more effective than those with
poor blood sugar control.
Rheumatoid arthritis (RA)
Studies are mixed as to whether evening primrose oil (EPO) helps reduce
symptoms of RA. Preliminary evidence suggests EPO may reduce pain, swelling,
and morning stiffness, but other studies have found no effect. When using GLA
for symptoms of arthritis, it may take 1 to 3 months for benefits to appear. It is
unlikely that EPO would help stop progression of the disease. So joint damage
would still occur.
Allergies
Omega-6 fatty acids from food or supplements, such as GLA from EPO or other
sources, have a longstanding history of folk use for allergies. Women who are
prone to allergies appear to have lower levels of GLA in breast milk and blood.
However, there is no good scientific evidence that taking GLA helps reduce allergy
symptoms. Well-conducted research studies are needed.
Before you try GLA for allergies, work with your doctor to determine if it is safe
for you. Then follow your allergy symptoms closely for any signs of improvement.
Attention deficit/hyperactivity disorder (ADHD)
Clinical studies suggest that children with ADHD have lower levels of EFAs, both
omega-6s and omega-3s. EFAs are important to normal brain and behavioral
function. Some studies indicate that taking fish oil (containing omega-3 fatty
acids) may help reduce ADHD symptoms, though the studies have not been well
designed. Most studies that used EPO have found it was no better than placebo at
reducing symptoms.
20
Maesha Musarrat (Lipids)
Breast cancer
One study found that women with breast cancer who took GLA had a better
response to tamoxifen (a drug used to treat estrogen-sensitive breast cancer)
than those who took only tamoxifen. Other studies suggest that GLA inhibits
tumor activity among breast cancer cell lines. There is some research suggesting
that a diet rich in omega-6 fatty acids may promote breast cancer development.
DO NOT add fatty acid supplements, or any supplements, to your breast cancer
treatment regimen without your doctor's approval.
Eczema
Evidence is mixed as to whether EPO can help reduce symptoms of eczema.
Preliminary studies showed some benefit, but they were not well designed. Later
studies that examined people who took EPO for 16 to 24 weeks found no
improvement in symptoms. If you want to try EPO, talk to your doctor about
whether it is safe for you.
High blood pressure (hypertension)
Preliminary evidence suggests that GLA may help reduce high blood pressure,
either alone or in combination with omega-3 fatty acids found in fish oil, namely
eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). In one study, men
with borderline high blood pressure who took 6g of blackcurrant oil had a
reduction in diastolic blood pressure compared to those who took placebo.
Another study examined people with intermittent claudication, which is pain in
the legs while walking that is caused by blockages in the blood vessels. Those who
took GLA combined with EPA had a reduction in systolic blood pressure compared
to those who took placebo.
More research is needed to see whether GLA is truly effective for hypertension.
Menopausal symptoms
EPO has gained popularity as a way to treat hot flashes associated with
menopause. But so far studies have been inconclusive.
21
Maesha Musarrat (Lipids)
Breast pain (mastalgia)
Some evidence suggests that EPO may reduce breast pain and tenderness in
people with cyclic mastalgia. It may also help reduce symptoms to a lesser extent
in people with noncyclic mastalgia. However, it does not seem to be effective for
severe breast pain.
Multiple sclerosis (MS)
EPO has been suggested as an additional treatment (along with standard therapy)
for MS, although there is no scientific evidence that it works. People with MS who
want to add EPO to their treatment regimens should talk with a health care
provider.
Osteoporosis
Some studies suggest that people who do not get enough essential fatty acids
(particularly EPA and GLA) are more likely to have bone loss than those with
normal levels of these fatty acids. In a study of women over 65 with osteoporosis,
those who took EPA and GLA supplements had less bone loss over 3 years than
those who took placebo. Many of these women also experienced an increase in
bone density.
Premenstrual syndrome (PMS)
Although most studies have found no effect, some women report relief of PMS
symptoms when using GLA. The symptoms that seem to improve the most are
breast tenderness and feelings of depression, as well as irritability and swelling
and bloating from fluid retention.
22
Maesha Musarrat (Lipids)
Omega-6/Omega-3 ratio: (2011, 2009, 2008)
Modern Western diets typically have ratios of omega-6 to omega-3 in excess of 10
to 1, some as high as 30 to 1; the average ratio of omega-6 to omega-3 in the
Western diet is 15:1–16.7:1.
Healthy ratios of omega-6:omega-3, according to some authors, range from 1:1 to
1:4. Other authors believe that a ratio of 4:1 (4 times as much omega-6 as omega3) is already healthy.
The importance of the ratio of omega-6/omega-3 essential fatty acids:
Excessive amounts of omega-6 polyunsaturated fatty acids (PUFA) and a very high
omega-6/omega-3 ratio, as is found in today's Western diets, promote the
pathogenesis of many diseases, including cardiovascular disease, cancer, and
inflammatory and autoimmune diseases, whereas increased levels of omega-3
PUFA (a low omega-6/omega-3 ratio) exert suppressive effects.
▪ In the secondary prevention of cardiovascular disease, a ratio of 4/1 was
associated with a 70% decrease in total mortality.
▪ A ratio of 2.5/1 reduced rectal cell proliferation in patients with colorectal
cancer, whereas a ratio of 4/1 with the same amount of omega-3 PUFA had
no effect.
▪ The lower omega-6/omega-3 ratio in women with breast cancer was
associated with decreased risk. A ratio of 2-3/1 suppressed inflammation in
patients with rheumatoid arthritis, and
▪ a ratio of 5/1 had a beneficial effect on patients with asthma, whereas a
ratio of 10/1 had adverse consequences. studies indicate that the optimal
ratio may vary with the disease under consideration.
[SOURCE: https://www.ncbi.nlm.nih.gov/pubmed/12442909]
omega-6:omega-3 ratio has significant influence on the ratio and rate of
production of eicosanoids, a group of hormones intimately involved in the body's
inflammatory and homeostatic processes, which include the prostaglandins,
leukotrienes, and thromboxanes, among others. Altering this ratio can change the
23
Maesha Musarrat (Lipids)
body's metabolic and inflammatory state. In general, grass-fed animals
accumulate more omega-3 than do grain-fed animals, which accumulate relatively
more omega-6. Metabolites of omega-6 are more inflammatory (esp. arachidonic
acid) than those of omega-3. This necessitates that omega-6 and omega-3 be
consumed in a balanced proportion.
[Source: https://en.wikipedia.org/wiki/Omega-3_fatty_acid]
Ratios of omega-6: omega-3 in some foods
Canola oil - 2:1, Walnut oil – 5:1, olive oil 13:1, English walnut – 4:1, pumpkin
seeds-114:1, sunflower oil- 19:1 etc
24
Maesha Musarrat (Lipids)
❖ Level of different types of lipid in the human body:
Total cholesterol levels:
•
•
•
Desirable: Below 200 mg/dL
Borderline high: 200 to 239 mg/dL
High: Above 240 mg/dL
LDL cholesterol levels:
•
•
•
•
•
Optimal for people with heart disease or who are at high risk: Below 70
mg/dL
Optimal for people at risk of heart disease: Below 100 mg/dL
Optimal: 100 to 129 mg/dL
Borderline high: 130 to 159 mg/dL
High: 160 to 189 mg/dL
HDL cholesterol levels:
•
•
•
Poor: Below 40 mg/dL
Acceptable: 40 to 59 mg/dL
Optimal: 60 or above mg/dL
Triglyceride levels:
•
•
•
Optimal: Below 150 mg/dL
Borderline high: 150 to 199 mg/dL
High: Above 200 mg/dL
25
Maesha Musarrat (Lipids)
❖ Cholesterol:
The word cholesterol is derived from the Ancient Greek hole (bile)
and stereos (solid) followed by the chemical suffix ol for an alcohol, is
an organic molecule. Cholesterol is found exclusively in animals; hence it is often
called as animal sterol. The total body content of cholesterol in an adult man
weighing 7Okg is about 140g i.e. around 2 g/kg body weight. Cholesterol is
amphipathic in nature, since it possesses both hydrophilic and hydrophobic
regions in the structure.
Structure of Cholesterol:
26
Maesha Musarrat (Lipids)
The Pathways of Cholesterol Metabolism: (2014, 2011, 2008)
Plasma cholesterol concentrations are maintained by biosynthesis through the
endogenous pathway and absorption of dietary and biliary cholesterol through
the exogenous pathway. In the endogenous pathway, cholesterol is synthesized
by the liver and extra hepatic tissues and secreted into plasma, whereas the
intestine is the primary site of the exogenous pathway of dietary cholesterol
uptake. Alteration of either pathway will affect the concentration of plasma
cholesterol.
Figure: The endogenous and exogenous pathways of cholesterol metabolism.
HDL= high-density lipoprotein; VLDL= very-low-density lipoprotein; IDL=
intermediate density lipoprotein; LDL= low-density lipoprotein; LDL-R= lowdensity lipoprotein receptor.
27
Maesha Musarrat (Lipids)
▪ Endogenous pathway:
Cholesterol from the liver can be secreted into the bile or can be incorporated, as
the free or esterified form, into lipoproteins, namely very-low-density lipoprotein
(VLDL) and LDL, which are then secreted into plasma. Elevated levels of
cholesterol in the liver will lead to an increased production of VLDL and/or LDL, as
well as down-regulation of the LDL receptor. The increase in lipoprotein
production and the decrease in LDL clearance can both lead to an elevation in
plasma cholesterol level.
Figure: Exogenous pathway of cholesterol metabolism. ACAT= acyl CoA:
cholesterol acyltransferase; CE= cholesteryl ester; FC= free cholesterol.
▪ Exogenous pathway:
Cholesterol is derived from bile and from dietary sources, which predominantly
comprise animal and dairy food products. In the intestinal lumen, if the
cholesterol is esterified, the ester is cleaved from the cholesterol moiety by
28
Maesha Musarrat (Lipids)
pancreatic cholesteryl ester hydrolase, which is produced by the exocrine
pancreas. Free cholesterol, along with other lipids and fat-soluble vitamins, is
then solubilized into micelles and is subsequently absorbed by enterocytes by a
mechanism that is not completely understood. After absorption, the free
cholesterol is re-esterified to cholesteryl ester by acyl CoA:cholesterol
acyltransferase (ACAT), and is packaged with other lipids into chylomicrons, which
are secreted into the mesenteric lymph and ultimately into plasma. Once in
circulation, chylomicrons are hydrolyzed by lipoprotein lipase at the endothelial
surface of vessels and are reduced to chylomicron remnants. These chylomicron
remnants can then be removed from the circulation by the liver or, if they are
small enough, may be able to penetrate the endothelial surface of the arterial
wall, where they may contribute to plaque formation.
Figure: Exogenous and Endogenous pathway of cholesterol metabolism
29
Maesha Musarrat (Lipids)
▪ Reverse cholesterol pathway:
Reverse cholesterol pathway refers to the process by which cholesterol is
removed from the tissues and returned to the liver. HDL is the key lipoprotein
involved in reverse cholesterol transport and the transfer of cholesteryl esters
between lipoproteins. The smallest and most dense lipoprotein particle is HDL.
HDL is formed through a maturation process where nascent HDL is secreted by
the liver and intestine and proceeds through a series of conversions (known as
the "HDL cycle") to attract cholesterol from cell membranes and free cholesterol
to the core of the HDL particle. It has been suggested that the action of
cholesteryl ester transfer protein transforms HDL into a TAG-rich particle that
interacts with hepatic-triglyceride lipase. Cholesterol ester-rich HDL may also be
taken up directly by the receptors in the liver. Another mechanism may be that
cholesterol esters are delivered directly to the liver for uptake without catabolism
of the HDL cholesterol particle. In relation to pathological change it has been
accepted that higher levels of HDL are associated with lower levels of heart
disease, therefore higher levels of HDL are considered to be protective. In
contrast, it is accepted that other lipoproteins, including VLDL, IDL, LDL, and the
remnant particles rendered in lipid processing, are highly atherogenic. The term
"non-HDL cholesterol" has been adopted to describe this increased risk reflected
in the lipid profile that may not be otherwise identified by simply examining the
LDL alone. Non-HDL cholesterol therefore encompasses a broader indication of
cardiovascular disease risk.
30
Maesha Musarrat (Lipids)
Figure: Metabolism of Cholesterol
Diseases related to Cholesterol metabolism: (2014, 2011)
In healthy individuals, the total plasma cholesterol is in the range of 150-200
mg/dl. In the new born, it is less than 100 mg/dl and rises to about 150 mg/dl
within a year. There are two consequences of cholesterol metabolism disorder in
the human body –
A. Hypercholesterolemia
B. Hypocholesterolemia
31
Maesha Musarrat (Lipids)
A.Hypercholesterolemia:
Increase in plasma cholesterol (> 200 mg/dl) concentration is known as
hypercholesterolemia. Hypercholesterolemia is also called dyslipidemia. It causes
many diseases.
1. Diabetes mellitus: Due to increased cholesterol synthesis since the availability
of acetyl CoA is increased.
2. Hypothyroidism (myxedema): This is believed to be due to decrease in the high
density lipoprotein (HDL) receptors on hepatocytes.
3. Obstructive jaundice: Due to an obstruction in the excretion of cholesterol
through bile.
4. Nephrotic syndrome: Increase in plasma globulin concentration is the
characteristic feature of nephrotic syndrome. Cholesterol elevation is due to
increase in plasma lipoprotein fractions in this disorder.
5. Atherosclerosis: Atherosclerosis is characterized by deposition of cholesteryl
esters and other lipids in the intima of the arterial walls often leading to
hardening of coronary arteries and cerebral blood vessels.
6. High blood pressure: When the arteries become hardened and narrowed with
cholesterol plaque and calcium, the heart has to strain much harder to pump
blood through them. As a result, blood pressure becomes abnormally high.
7. Coronary heart disease: If the cholesterol level is too high, cholesterol can
build up in the walls of arteries. This causes arteries to become narrowed, which
slows the blood flow to the heart muscle. Reduced blood flow can result
in angina (chest pain) or in a heart attack if a blood vessel gets blocked
completely.
32
Maesha Musarrat (Lipids)
8. Stroke: Due to deposition of cholesterol, arteries that lead to the brain become
narrowed and even blocked. If a vessel carrying blood to the brain is blocked
completely, it can cause a stroke.
9. Peripheral Vascular Disease: High cholesterol is also linked to peripheral
vascular disease. This refers to diseases of blood vessels outside the heart and
brain. In this condition, cholesterol deposits build up along artery walls and affect
blood circulation. This occurs mainly in arteries that lead to the legs and feet.
B.Hypocholesterolemia:
Hypocholesterolemia is defined as a total serum cholesterol level lower than 120
mg/dl. However, some authors suggest a cut-off level to be 160 mg/dl. The most
common clinical situations related to hypocholesterolemia are given below –
1. Anemias: Hypocholesterolemia has been described in various types of chronic
anemia which include: congenital dyserythropoietic anemia, congenital
spherocytosis, sickle cell anemia, beta thalassemia, aplastic anemia, and
sideroblastic anemia. Increased erythropoietic activity in various anemias is
proposed as a mechanism that consumes plasma pool of cholesterol for the
construction of cell membranes of the young erythrocytes. Low levels of serum
cholesterol and other lipids suggested severe bone marrow failure and
irresponsiveness to therapy in aplastic anemia patients.
2. Malabsorption: Hypocholesterolemia is observed in celiac disease. There was
hypocholesterolemia in 35% of pediatric patients with celiac disease. Reduced
intestinal lipolysis observed in pancreatitis also results with hypocholesterolemia.
3. Hyperthyroidism: Hyperthyroidism is associated with hypocholesterolemia
characterized by a reduction in total cholesterol, HDL and LDL. There is an
upregulation of LDL receptor gene expression as well as increased lipoprotein
lipase activity that result with increased lipoprotein clearance from the plasma.
Thyroid hormones stimulate cholesterol ester transfer protein, an enzyme that
transports cholesterol esters from HDL to VLDL which is metabolized by
33
Maesha Musarrat (Lipids)
lipoprotein lipase in adipose tissue and muscle. All of these factors promote a
lower blood cholesterol level.
4. Infection, inflammation and sepsis: Transient hypocholesterolemia and
hypertriglyceridemia are observed at the initial phase of bacterial infections of
various origin. Hypocholesterolemia was reported in malaria infection and has the
strongest positive predictive value (96%) among parameters for malaria diagnosis.
Hypocholesterolemia is a typical laboratory finding in severe chronic hepatic
insufficiency due to viral cirrhosis. It was found that serum cholesterol levels were
low in tuberculosis infection and diet high in cholesterol helped the patients to
recover from the disease. Patients develop hypocholesterolemia during sepsis.
Hypocholesterolemia has been observed in several inflammatory diseases such as
rheumatoid arthritis, systemic lupus erythematosus and sarcoidosis.
❖ Membrane lipid: (2008, 2010)
Membrane lipids are lipids involved in forming the structure of biological
membranes – both the cell membrane and intracellular membranes – and in
membrane function. A membrane lipid is a compound which belongs to a group
of structurally similar to fats and oils which form the double-layered surface of all
cells (lipid bilayer). These lipids are amphiphilic: they have one end that is soluble
in water ('polar') and an ending that is soluble in fat ('nonpolar'). By forming a
double layer with the polar ends pointing outwards and the nonpolar ends
pointing inwards membrane lipids can form a 'lipid bilayer' which keeps the
watery interior of the cell separate from the watery exterior. The arrangements of
lipids and various proteins, acting as receptors and channel pores in the
membrane, control the entry and exit of other molecules and ions as part of the
cell's metabolism.
34
Maesha Musarrat (Lipids)
Figure: Lipid bilayer
Types of membrane lipids:
The three major classes of membrane lipids are
a) Phospholipids,
b) Glycolipids, and
c) Cholesterol
The structures of membrane lipids are given below –
35
Maesha Musarrat (Lipids)
(a) Phospholipids:
The major class of membrane lipids is the phospholipids. They are abundant in all
biological membranes. Phospholipids are made from four components: one or
more fatty acids, a platform to which the fatty acids are attached, a phosphate,
and an alcohol attached to the phosphate. The fatty acid portion provides the
hydrophobic barrier found in lipids, whereas the rest of the molecule has a
hydrophilic property, enabling interaction with the aqueous environment.
Phospholipids are built upon a foundation of glycerol, a three-carbon alcohol,
or sphingosine. Phospholipids which are derived from glycerol are also known
as phosphoglycerides, which consist of a glycerol backbone where two fatty acid
chains and a phosphorylated alcohol are attached. The major phosphoglycerides
come from phosphatidate through the formation of an ester bond between the
phosphate group of phosphatidate and the hydroxyl group of one of several
alcohols. Sphingosine is a phospholipid found in membranes that is not derived
from glycerol. The backbone in sphingomyelin, however, is sphingosine, which is
an amino alcohol which contains a long, unsaturated hydrocarbon chain.
36
Maesha Musarrat (Lipids)
Figure: Types of Phospholipids
37
Maesha Musarrat (Lipids)
(b) Glycolipids:
Glycolipids are sugar-containing lipids. Glycolipids are typically composed of short,
branched chains with less than 15 sugar units. The sugar could be either glucose
or galactose.
Figure: Structure of Glycolipid
(c) Cholesterol:
Cholesterol is a steroid built from four linked hydrocarbon rings. A hydrocarbon
tale is at one end of the steroid while a hydroxyl group is attached to the other
end.
Figure: Structure of cholesterol
38
Maesha Musarrat (Lipids)
Functions of membrane lipids:
The functions of membrane lipids are –
• Working as diffusion barrier
• Controlling movement of Specific molecules
• Maintain shape of the cell
❖ Phospholipids: (2012)
Phospholipids are esters of fatty acid with alcohol attached to phosphoric acid
with or without nitrogen base. These are the derivatives of phosphatidic acid in
which the phosphate is esterified with the hydroxyl group (-OH) of a suitable
alcohol. In other words, phospholipids are complex or compound lipids,
composed of fatty acids, glycerol, phosphoric acid and in most cases a nitrogen
base.
Phospholipid = Fatty acid + Alcohol + Phosphoric acid + Nitrogen base
Location:
Phospholipids are present in biological membranes like cell membranes,
mitochondrial membrane in brain, nerve tissue and muscle.
Amphipathic nature of phospholipids: (2010)
An amphiphile is a term describing a chemical compound possessing both
hydrophilic (water-loving, polar) and lipophilic (fat-loving) properties. The
structure
of
the
phospholipid
molecule
generally
consists
of
two hydrophobic fatty acid "tails" and a hydrophilic "head" consisting of a
phosphate group. The phospholipid head contains a negatively charged
phosphate group and glycerol; it is hydrophilic (attracted to water). The
phospholipid tails usually consists of 2 long fatty acid chains; they
are hydrophobic and are repelled by water. When placed in water, phospholipids
form a variety of structures depending on the specific properties of the
39
Maesha Musarrat (Lipids)
phospholipid with tails typically aggregating to minimize interactions with water
molecules. These specific properties allow phospholipids to play an important role
in the phospholipid bilayer. In biological systems, the phospholipid often occur
with other molecules (e.g., proteins, glycolipids, sterols) in a bilayer such as a cell
membrane. Lipid bilayers occur when hydrophobic tails line up against one
another, forming a membrane of hydrophilic heads on both sides facing the
water.
Figure: Amphipathic nature of Phospholipid
Classification of Phospholipids: (2010)
Phospholipids are two classes of phospholipids
A. Glycerophospholipids (or phosphoglycerides) that contain glycerol as the
alcohol.
B. Sphingophospholipids (or sphingomyelins) that contains phingosinea s the
alcohol.
40
Maesha Musarrat (Lipids)
A. Glycerophospholipids:
Glycerophospholipids are the major lipids that occur in biological membranes.
They consist of glycerol 3-phosphate esterified at its C1 and C2 with fatty acids.
Usually, C1 contains a saturated fatty acid while C2 contains an unsaturated fatty
acid.
1. Phosphatidic acid : This is the simplest phospholipid. lt does not occur in good
concentration in the tissues. Basically, phosphatidic acid is an intermediate in the
synthesis of triacylglycerols and phospholipids. The other glycerophospholipids
containing different nitrogenous bases or other groups may be regarded as the
derivatives of phosphatidic acid.
2. Lecithins (phosphatidylcholine): These are the most abundant group of
phospholipids in the cell membranes. Chemically, lecithin (Greek : lecithos-egg
yolk) is a phosphatidic acid with choline as the base. Phosphatidylcholines
represent the storage form of body's choline.
i.
ii.
Dipalmitoyl lecithin: It is an important phosphatidylcholine found in lungs.
lt is a surface active agent and prevents the adherence of inner surface of
the lungs due to surface tension. Respiratory distress syndrome in infants is
a disorder characterized by the absence of dipalmitoyl lecithin.
Lysolecithin: It is formed by removal of the fatty acid either at C1 or C2 of
lecithin.
3. Cephalins (phosphatidylethanolamine): Ethanolamine is the nitrogenous base
present in cephalins. Thus, lecithin and cephalin differ with regard to the base.
4. Phosphatidylinositol: The steroisomer myo-inositol is attached to phosphatidic
acid to give phosphatidylinositol (Pl). This is an important component of cell
membranes. The action of certain hormones (e.g. oxytocin, vasopressin) is
mediated through Pl.
5. Phosphatidylserine: The amino acid serine is present in this group of
glycerophospholipids. Phosphatidylthreonine is also found in certain tissues.
41
Maesha Musarrat (Lipids)
42
Maesha Musarrat (Lipids)
6. Plasmalogens: When a fatty acid is attached by an ether linkage at C1 of
glycerol in the glycerophospholipids, the resultant compound is plasmalogen.
Phosphatidalethanolamine is the most imoortant which is similar in structure to
phosphatidylethanolamine but for the ether linkage (in place of ester). An
unsaturated fatty acid occurs at C1. Choline, inositol and serine may substitute
ethanolamine to give other plasmalogens.
7. Cardiolipin : lt is so named as it was first isolated from heart muscle.
Structurally, a cardiolipin consists of two molecules of phosphatidic acid held by
an additional glycerol through phosphate groups. lt is an important component of
inner mitochondrial membrane. Cardiolipin is the only phosphoglyceride that
possesses antigenic properties.
B. Sphingomyelins:
Sphingosine
is
an
amino
alcohol
present
in
sphingomyelins
(sphingophospholipidh). They do not contain glycerol at all. Sphingosine is
attached by anamide linkage to produce ceramide. The alcohol group of
sphingosine is bound to phosphorylcholine in sphingomyelin structure.
Sphingomyelins are important constituents of myelin and are found in good
quality in brain and in nervous system.
Functions of Phospholipids:
Phospholipids constitute an important group of compound lipids that perform a
wide variety of functions. Such as 1. In association with proteins, phospholipids form the structural components of
membranes and regulate membrane permeability.
2. Phospholipids (lecithin, cephalin and cardiolipin) in the mitochondria are
responsible for maintaining the conformation of electron transport chain
components, and thus cellular respiration.
3. Phospholipids participate in the absorption of fat from the intestine.
43
Maesha Musarrat (Lipids)
4. Phospholipids are essential for the synthesis of different lipoproteins, and thus
participate in the transport of lipids.
5. Accumulation of fat in liver (fatty liver) can be prevented by phospholipids,
hence they are regarded as lipotropic factors.
6. Arachidonic acid, an unsaturated fatty acid liberated from phospholipids,
serves as a precursor for the synthesis of eicosanoids (prostaglandins,
prostacyclins, thromboxanes etc.).
7. Phospholipids participate in the reverse cholesterol transport and thus help in
the removal of cholesterol from the body.
8. Phospholipids act as surfactants (agents lowering surface tension). For
instance, dipalmitoyl phosphatidylcholine is an important lung surfactant.
Respiratory distress syndrome in infants is associated with insufficient production
of this surfactant.
9. Cephalins, an important group of phospholipids participate in blood clotting.
10. Phospholipids (phosphatidylinositol) are involved in signal transmission across
membranes.
❖ Ecosanoids: (2014, 2013, 2009)
The ord e osa oid is deri ed fro the Greek ord ei osa
hi h ea s
twenty. Ecosanoids are 20 carbon compounds, derived from arachidonic acid and
some other 20 carbon polyunsaturated fatty acids.
Ecosanoids are –
•
•
•
•
•
Prostaglandins (PG)
Prostacyclins (PGI)
Thromboxanes (TX)
Leukotrienes (LT)
Lipoxins (LX)
44
Maesha Musarrat (Lipids)
These molecules almost always act on the cells that produce them or on
neighboring cells i.e. over short distances and time periods and therefore can be
classified as autocrine or paracrine hormones. Ecosanoids are also known as local
hormones. They exert complex control over many bodily systems, mainly in
inflammation or immunity, and as messengers in the central nervous system.
Ecosa oids are Local Hor o es : 2009
The eicosanoids are considered "local hormones". They have specific effects on
target cells close to their site of formation. Local hormones are secreted into the
interstitial fluid and they act locally in two ways. Some hormones act on the
neighboring cells and are known as paracrine hormones and some hormones act
on the cells from which they were secreted, they are autocrine hormones.
Physiologically and pathologically, eicosanoids are local hormones.They are synth
esized and exert their biological actions in the same tissue. The specific effect of
each eicosanoid depends on sequential enzymatic machinery in a specific cell,
yielding a specific eicosanoid, exerting its distinct function. They act on cells close
to their site of production. Eicosanoids also rapidly break down, so they are not
able to travel very far. Therefore, they are released by most cells, act on that
same cell or nearby cells (i.e., they are autocrine and paracrine mediators), and
then are rapidly inactivated.
From the above discussion it can be concluded that the eicosanoids are
considered "local hormones" as • They have specific effects on target cells close to their site of formation.
• They are rapidly degraded, so they are not transported to distal sites
within the body.
45
Maesha Musarrat (Lipids)
Major pathways of eicosanoids metabolism: (2012)
There are two major pathways of eicosanoid metabolism. These are –
1.Cyclic pathway
2.Linear pathway
1.Cyclic pathway: (Role of Cyclooxygenase) 2008
In cyclic pathway production of prostaglandins, prostacyclins, and thromboxanes
take place from arachidonic acid. Cyclooxygenase enxyme acts in this cycle.
Prostaglandin H2 Synthase (PGH2 synthase) catalyzes the committed step in the
li path a that leads to produ tio of prostagla di s, prosta li s, &
thromboxanes.
Different cell types convert PGH2 to different compounds. Prostaglandin
H2 Synthase is a heme-containing dioxygenase, bound to endoplasmic reticulum
membranes.
It exhibits two catalytic activities, Cyclooxygenase and Peroxidase. The enzyme
expressing both activities is sometimes referred to as Cyclooxygenase (COX).
The interacting cyclooxygenase and peroxidase reaction pathways are complex.
A peroxide (such as that generated later in the reaction sequence) oxidizes the
heme iron. The oxidized heme accepts an electron from a nearby tyrosine residue
(Tyr385). The resulting tyrosine radical is proposed to extract a hydrogen atom
from arachidonate, generating a radical species that reacts with O2.
The signal molecule NO (nitric oxide) may initiate prostaglandin synthesis by
reacting with superoxide anion (O2-) to produce peroxynitrite, which oxidizes the
heme iron enabling electron transfer from the active site tyrosine. Prostaglandin
synthesis in response to some inflammatory stimuli is diminished by inhibitors of
Nitric Oxide Synthase.
46
Maesha Musarrat (Lipids)
Figure: Cyclic pathway of ecosanoid metabolism
Two isoforms of PGH2 Synthase are designated COX-1 and COX-2 (Cyclooxygenase
1 & 2). COX-1 is constitutively expressed at low levels in many cell types. COX-2
expression is highly regulated. Transcription of the gene for COX-2 is
stimulated by growth factors, cytokines, and endotoxins COX-2 expression may
be enhanced by cAMP, and in many cells PGE2 produced as a result of COX-2
activity itself leads to changes in cAMP levels.
Though
both
cyclooxygenase
isoforms
catalyze
PGH2 formation,
differing localization within a cell, and localization of enzymes that convert
PGH2 into particular prostaglandins or thromboxanes, may result in COX-1 and
COX-2 yielding different ultimate products.
COX-1 is essential for thromboxane formation in blood platelets, and for
maintaining integrity of the gastrointestinal epithelium. Inflammation is
47
Maesha Musarrat (Lipids)
associated with up-regulation of COX-2 and increased formation of
particular prostaglandins. COX-2 levels increase in inflammatory diseases such as
arthritis.
Increased COX-2 expression is seen in some cancer cells. Angiogenesis (blood
vessel development), which is essential to tumor growth, requires COX-2.
Overexpression of COX-2 leads to increased expression of VEGF (vascular
endothelial growth factor). Regular use of NSAIDs has been shown to decrease
the risk of developing colorectal cancer.
2.Linear pathway: (Role of Lipooxygenase) 2008
In linear pathway, leukotrienes are produced from arachidonic acid. The first step
of the linear pathway for synthesis of leukotrienes is catalyzed by lipoxygenase.
Mammalian organisms have a family of lipoxygenase enzymes that catalyze
oxygenation of various polyunsaturated fatty acids at different sites. Many of the
products have signal roles. For example, 5-Lipoxygenase, found in leukocytes,
catalyzes conversion of arachidonate to 5-HPETE (5-hydroperoxyeicosatetraenoic
acid). 5-HPETE is converted to leukotriene-A4, which in turn may be converted to
various other leukotrienes.
A non-heme iron is the prosthetic group of ipoxygenase enzymes. Ligands to the
iron include 4 histidine nitrogen atoms and the C-terminal carboxylate oxygen.
The arachidonate substrate binds in a hydrophobic pocket, adjacent to the
catalytic iron atom. O2 is thought to approach from the opposite side of the
substrate than the side facing the iron, for a stereospecific reaction.
The reaction starts with extraction of a hydrogen from arachidonate, with transfer
of the electron to the iron, reducing it from Fe3+ to Fe2+. The fatty acid
radical reacts with O2 to form a hydroperoxy fatty acid. Which hydrogen is
extracted, & the position of the resulting hydroperoxy group, varies with different
lipoxygenases. Additional reactions then yield the various leukotrienes.
Leukotrienes have roles in inflammation. They are produced in areas of
inflammation in blood vessel walls as part of the pathology of atherosclerosis.
Leukotrienes are also implicated in asthmatic constriction of the bronchioles.
48
Maesha Musarrat (Lipids)
Figure: linear pathway of ecosanoid metabolism
❖ Enterohepatic circulation of Bile acids and Bile salts:
(2010)
In an enterohepatic cycle, a substance is secreted by the liver into the bile, passes
into the intestine and is taken up again into the blood, either by passive diffusion
across cell membranes or by active transport. Since blood drained from the
intestines feeds into the portal vein, the substance will return to the liver, where
it may be captured by liver cells and once again secreted into the bile.
The enterohepatic circulation of bile salts is the recycling of bile salts between the
small intestine and the liver. The total amount of bile acids in the body, primary or
49
Maesha Musarrat (Lipids)
secondary, conjugated or free, at any time is defined as the total bile acid pool. In
healthy people, the bile acid pool ranges from 2 to 4 g.
The enterohepatic circulation of bile acids in this pool is physiologically extremely
important. By cycling several times during a meal, a relatively small bile acid pool
can provide the body with sufficient amounts of bile salts to promote lipid
absorption. In a light eater, the bile acid pool may circulate 3 to 5 times a day, in a
heavy eater; it may circulate 14 to 16 times a day.
The conjugated bile salts synthesized in the liver accumulate in gall bladder. From
there they are secreted into the small intestine where they serve as emulsifying
agents for the digestion and absorption of fats and fat soluble vitamins. A large
portion of the bile salts (primary and secondary) are reabsorbed and returned to
the liver through portal vein. Thus the bile salts are recycled and reused several
times in a day. This is the mechanism of enterohepatic circulation. About 15-30 g
of bile salts are secreted into the intestine each day and reabsorbed. However, a
small portion of about 0.5 g/day is lost in the feces. An equal amount (0.5 g/day)i
s synthesized in liver to replace the lost bile salts. The fecal excretion of bile salts
is the only route for the removal of cholesterol from the body.
50
Maesha Musarrat (Lipids)
Bile salts are recycled out of the small intestine in four ways:
(1) passive diffusion along the small intestine (plays a relatively minor role);
(2) carrier-mediated active absorption in the terminal ileum (the most important
absorption route);
(3) de-conjugation to primary bile acids before being absorbed either passively or
actively;
(4) conversion of primary bile acids to secondary bile acids with subsequent
absorption of deoxycholic acid.
51
Maesha Musarrat (Lipids)
❖
The rate limiting step in bile acid synthesis: (2012)
The bile acids possess 24 carbon atoms, 2 or 3 hydroxyl groups in the steroid
nucleus and a side chain ending in carboxyl group. The bile acids are amphipathic
in nature since they possess both polar and non-polar groups. They serve as
emulsifying agents in the intestine and actively participate in the digestion and
absorption of lipids. Synthesis of two primary bile acids – cholic acid (CA) and
chenodeoxycholic acid (CDCA) from cholesterol which is catalyzed by the 7αhydroxylase enzyme is the rate limiting step in bile acid synthesis.
52
Maesha Musarrat (Lipids)
Figure: Outline of bile acid synthesis (*- primary bile acids, **- secondary bile
acids)
The synthesis of primary bile acids takes place in the liver and involves a series of
reactions. The step catalysed by 7 a-hydroxylase is inhibited by bile acids and this
is the rate Iimiting reaction. Cholic acid and chenodeoxycholic acid are the
primary bile acids and the former is found in the largesat mount in bile. On
conjugation with glycine or taurine, conjugated bile acids (glycocholic acid,
taurocholic acid etc.) are formed which are more efficient in their function as
surfactants. In the bile, the conjugated bile acids exist as sodium and potassium
salts which are known as bile salts. In the intestine a portion of primary bile acids
undergoes deconjugation and dehydroxylation to form secondary bile acids
(deoxycholic acid and lithocholic acid). These reactions are catalyzed by bacterial
enzymes in the intestine.
53
Maesha Musarrat (Lipids)
❖ Prostaglandins:
Prostaglandins are 20-carbon hydroxyl fatty acids containing a five-membered
ring. These are widely distributed in lungs, kidney, thyroid, spleen, brain, iris,
endometrium etc. The dietary precursor of the prostaglandins is the essential
fatty acid, linoleic acid. It is elongated and desaturated to arachidonic acid, the
immediate precursor of the prostaglandins.
54
Maesha Musarrat (Lipids)
Figure: Prostaglandins with substituent groups and structures
55
Maesha Musarrat (Lipids)
Structure of Prostaglandins:
Prostaglandins are derivatives of a hypothetical 2O-carbon fatty acid namely
prostanoic acid hence known as prostanoids. This has a cyclopentane ring (formed
by carbon atoms 8 to 12) and two side chains, with carboxyl group on one side.
Prostaglandinds differ in their structure due to substituent group and double
bond on cyclopentane ring. The different prostaglandins are given in the above
figure.
Synthesis of Prostaglandins:
Arachidonic acid (5, 8, 11, 14 –eicosatetraenoic acid) is the precursor for the most
of the prostaglandins in humans. The biosynthesis of prostaglandins was
described by scene Bregstrom and Bengt Samulsson in 1960. It occurs in the
endoplasmic reticulum in the following stages –
First stage –
Release of arachidonic acid from membrane bound phospholipids by
phospholipaseA2 . This reaction occurs due to a specific stimuli by hormones such
as epinephrine or bradykinin.
Second stage –
Oxidation and cyclization of arachidonic acid to PGG2 which is then converted to
PGH2 by a reduced glutathione dependent peroxidase.
Third stage –
PGH2 serves as the immediate precursor for the synthesis of a number of
prostaglandins, including prostacyclins and thrombosis.
The a o e path a is k o
as cyclic pathway of arachidonic acid .
56
Maesha Musarrat (Lipids)
Figure: Overview of biosynthesis of prostaglandins and related compounds
(5-HPETE-5-Hydroxyperoxycicosatetraenoic acid; PG-Prostaglandins; PGI2Prostacyclin I2, TXA2-Thromboxane A2)
Biochemical Functions of Prostaglandins: (2010)
Prostaglandins act as local hormones in their function. They are produced in
almost all the tissues. They are degraded to inactive products at the site of their
production instead of remain stored. Prostaglandins are involved in a variety of
biological functions. The actions of prostaglandins differ in different tissues.
Sometimes prostaglandins bring about opposing actions in the same tissue.
57
Maesha Musarrat (Lipids)
Over production of prostaglandins result in many symptoms which include pain,
fever, nausea, vomiting and inflammation. The biochemical functions of
prostaglandins are described below –
1. Regulation of blood pressure:
The prostaglandins (PGE, PGA and PGl2) are vasodilator in function. This results in
increased blood flow and decreased peripheral resistance to lower the blood
pressure. Prostaglandins serve as agents in the treatment of hypertension.
2. Inflammation:
The prostaglandins PGE1 and PGE2 induce the symptoms of inflammation
(redness, swelling, edema etc.) due to arteriolar vasodilation. This led to the belief
that prostaglandins are natural mediators of inflammatory reactions of
rheumatoid arthritis (involving joints), psoriasis (skin), conjunctivitis (eyes) etc.
Corticosteroids are frequently used to treat these inflammatory reactions, since
they inhibit prostaglandin synthesis.
3. Reproduction:
Prostaglandins have widespread applications in the field of reproduction. PGE2
and PGF2 are used for the medical termination of pregnancy and induction of
Iabor. Prostaglandins are administered to cattle to induce estrus and achieve
better rate of fertilization.
4. Pain and Fever:
lt is believed that pyrogens (fever producing agents) promote prostaglandin
biosynthesis leading to the formation of PGE2 in the hypothalamus, the site of
regulation of body temperature. PGE2 along with histamine and bradykinin cause
pain. Migraine is also due to PGE2. Aspirin and other non-steroical drugs inhibit
prostaglandin synthesis and thus control fever and relieve pain.
58
Maesha Musarrat (Lipids)
5. Regulation of gastric secretion:
In general, prostaglandins (PGE) inhibit gastric secretion. Prostaglandins are used
for the treatment of gastric ulcers. However, prostaglandins stimulate pancreatic
secretion and increase the motility of intestine which often causes diarrhea.
6. Influence on immune system:
Macrophages secrete PGE which decreases the immunological functions of B-and
T –lymphocytes.
7. Effect on respiratory function:
PGE is a bronchodilator whereas PGF acts as a constrictor of bronchial smooth
muscles. Thus, PGE and PGF oppose the actions of each other in the lungs. PGE1
and PGE2 are used in the treatment of asthma.
8. Influence on renal function:
PGE increases glomerular filtration rate (GFR) and promotes urine output.
Excretion of Na+ and K+ is also increased by PGE.
9. Effects on metabolism:
Prostaglandins influence certain metabolic reactions, probably through the
mediation of cAMP. PGE decreases lipolysis, increases glycogen formation and
promotes calcium mobilization from the bone.
10. Platelet aggregation and Thrombosis:
The prostaglandins, namely prostacyclins (PGI2), inhibit platelet aggregation. On
the other hand, thromboxanes (TXA2) and prostaglandin E2 promote platelet
aggregation and blood clotting that might lead to thrombosis. PGl2, produced by
endothelial cells lining the blood vessels, prevents the adherence of platelets to
the blood vessels. TXA2 is released by the platelets and is responsible for their
spontaneous aggregation when the platelets come in contact with foreign
surface, collagen or thrombin. Thus, prostacyclins and thromboxanes are
antagonists in their action. In the overall effect PGl2 acts as a vasodilator, while
59
Maesha Musarrat (Lipids)
TXA2 is a vasoconstrictor. The balance between PGI2 and TXA2 is important in the
regulation of hemostasis and thrombosis.
❖ NSAIDs: (2010)
NSAIDs mean Non-Steroidal Anti-Inflammatory Drugs. NSAIDs are also known as
anti-inflammatories. According to U.S Food and Drug Administration (FDA),
NSAIDs are a group of drugs used to temporarily relieve pain and inflammation.
They work by blocking the production of prostaglandins, or chemicals believed to
be associated with pain and inflammation. NSAIDs temporarily relieve pain (in
pain like headache and period pain), reduce inflammation or swelling (in
conditions like arthritis and muscle and bone injuries) and lower a raised
temperature.
Classification of NSAIDs:
NSAIDs can be classified based on their chemical structure or mechanism of
action. Older NSAIDs were known long before their mechanism of action was
elucidated and were for this reason classified by chemical structure or origin.
Newer substances are more often classified by mechanism of action.
Salicylates
•
Aspirin (acetylsalicylic acid)
•
Diflunisal (Dolobid)
•
Salicylic acid and other salicylates
•
Salsalate (Disalcid)
Propionic acid derivatives
•
Ibuprofen
•
Dexibuprofen
•
Naproxen
60
Maesha Musarrat (Lipids)
•
Fenoprofen
•
Ketaprofen
•
Dexketoprofen
•
Flurbiprofen
•
Oxaprozin
•
Loxoprofen
Acetic acid derivatives
•
Indomethacin
•
Tolmetin
•
Sulindac
•
Etodolac
•
Ketorolac
•
Diclofenac
•
Aceclofenac
•
Nabumetone (drug itself is non-acidic but the active, principal metabolite
has a carboxylic acid group)
Enolic acid (Oxicam) derivatives
•
Piroxicam
•
Meloxicam
•
Tenoxicam
•
Droxicam
•
Lornoxicam
61
Maesha Musarrat (Lipids)
•
Isoxicam (withdrawn from market 1985)
•
Phenylbutazone (Bute)
Anthranilic acid derivatives (Fenamates)
The following NSAIDs are derived from fenamic acid. which is a derivative
of anthranilic acid, which in turn is a nitrogen isosterei of salicylic acid, which is
the active metabolite of aspirin.
•
Mefenamic acid
•
Meclofenamic acid
•
Flufenamic acid
•
Tolfenamic acid
Selective COX-2 inhibitors (Coxibs)
•
Celecoxib (FDA alert)
•
Parecoxib FDA withdrawn, licensed in the EU
•
Lumiracoxib TGA cancelled registration
•
Etoricoxib not FDA approved, licensed in the EU
•
Firocoxib used in dogs and horses
Sulfonanilides
•
Nimesulide (systemic preparations are banned by several countries for the
potential risk of hepatotoxicity)
Others
•
•
Clonixin
Licofelone acts by inhibiting LOX (lipooxygenase) & COX and hence known
as 5-LOX/COX inhibitor
62
Maesha Musarrat (Lipids)
•
H-harpagide in Figwort or Devil's Claw
Most Common Types of NSAIDs:
The four NSAIDs most often used to treat many types of back and neck pain are:
•
Aspirin (brand names include Bayer, Bufferin, and Ecotrin, St. Joseph)
•
Ibuprofen (Advil, Motrin)
•
Naproxen (Aleve, Anaprox DS, Naprosyn)
•
Celecoxib (Celebrex)
Other Forms of NSAIDs:
In addition to the above, NSAIDs come in forms other than those taken by mouth.
For example:
• Ketorolac can be given as an intravenous, intramuscular, or intranasal drug,
making it useful after surgery or if the patient cannot eat.
• Diclofenac is available topically as a gel (Voltaren), patch (Flector), or
solution (Pennsaid). The medication is applied directly to the area of pain.
Topical forms reduce gastrointestinal and other potential side effects of
NSAIDs.
Medical uses of NSAIDs:
NSAIDs are usually used for the treatment of acute or chronic conditions
where pain and inflammation are present.
NSAIDs are generally used for the symptomatic relief of the following conditions:
•
Osteoarthristis
•
Rheumatoid arthritis
•
Mild-to-moderate pain due to inflammation and tissue injury
•
Low back pain
63
Maesha Musarrat (Lipids)
•
Inflammatory arthropathies
•
Tennis elbow
•
Headache
•
Migraine
•
Acute gout
•
Dysmenorrhoea (menstrual pain)
•
Metastic bone pain
•
Postoperative pain
•
Muscle stiffness and pain due to Parkinso ’s disease
•
Pyrexia (fever)
•
Ileus
•
Renal colic
•
•
They are also given to neonate infants whose ductus arteriosus is not
closed within 24 hours of birth
Macular edema
Mechanism of action of NSAIDs:
Most NSAIDs act as nonselective inhibitors of the enzyme cyclooxygenase (COX),
inhibiting both the cyclooxygenase-1(COX-1) and cyclooxygenase-2(COX2) isoenzymes. This inhibition is competitively reversible as opposed to the
mechanism of aspirin, which is irreversible inhibition. COX catalyzes the formation
of prostaglandins and thromboxane from arachidonic acid. Prostaglandins act as
messenger molecules in the process of inflammation. This mechanism of
64
Maesha Musarrat (Lipids)
action was elucidated by John Vane (1927–2004), who received a Nobel Prize for
his work.
Prostaglandins are a family of chemicals that are produced by the cells of the
body and have several important functions. They promote inflammation that is
necessary for healing, but also results in pain and fever; support the blood clotting
function of platelets; and protect the lining of the stomach from the damaging
effects of acid.
Prostaglandins are produced within the body's cells by the enzyme
cyclooxygenase (COX). There are two COX enzymes, COX-1 and COX-2. Both
enzymes produce prostaglandins that promote inflammation, pain, and fever.
However, only COX-1 produces prostaglandins that support platelets and protect
the stomach. Nonsteroidal anti-inflammatory drugs (NSAIDs) block the COX
enzymes and reduce prostaglandins throughout the body. As a consequence,
ongoing inflammation, pain, and fever are reduced. Since the prostaglandins that
protect the stomach and support platelets and blood clotting also are reduced,
NSAIDs can cause ulcers in the stomach and promote bleeding.
Antipyretic activity of NSAIDs:
NSAIDS have antipyretic activity and can be used to treat fever. Fever is caused by
elevated levels of prostaglandins E2, which alters the firing rate of neurons within
the hypothalamus, that control thermoregulation. Antipyretics work by inhibiting
the enzyme COX, which causes the general inhibition of prostanoid biosynthesis
(PEG2) within the hypothalamus. PEG2 signals to the hypothalamus to increase the
body's thermal set point. Ibuprofen has been shown more effective as
an antipyretic than paracetamol (acetaminophen). Arachidonic acid is the
precursor substrate for cyclooxygenase leading to the production of
prostaglandins F, D & E.
65
Maesha Musarrat (Lipids)
Risks associated with using NSAIDs:
There are risks associated with all pain relievers. NSAIDs should be used with
caution, especially by people over the age of 65, those at risk of stomach or heart
problems, or those with asthma.
•
Gastrointestinal problems
The most common risk of standard NSAIDs is that they can cause ulcers and other
problems in esophagus, stomach, or small intestine.
•
High Blood Pressure and Kidney Damage
NSAIDs reduce the blood flow to the kidneys, which makes them work more
slowly. When kidneys are not working well, fluid builds up in the body. The more
fluid in bloodstream, the higher blood pressure.
•
Allergic Reactions
NSAIDs can also cause extreme allergic reactions, especially in people
with asthma, sinus problems or nasal polyps.
•
Photosensitivity
Photosensitivity is a commonly overlooked adverse effect of many of the NSAIDs.
•
During pregnancy
NSAIDs are not recommended during pregnancy, particularly during the third
trimester. While NSAIDs as a class are not direct teratogens, they may cause
premature closure of the fetal ductus arteriosus. Additionally, they are linked
with premature birth and miscarriage.
66
Maesha Musarrat (Lipids)
❖ COX-1 and COX-2: (2014, 2009)
The full for of COX is C loo ge ase. It is a e z e. Cyclooxygenase (COX) is
responsible for the formation of prostanoids. The three main groups of
prostanoids are prostaglandins, prostacyclins, and thromboxanes. Therefore,
cyclooxygenase is also known as prostaglandin-endoperoxide synthase (PTGS).
In the 1990, researchers discovered that two different COX isoenzymes are
existed. They are –
a. COX-1 and
b. COX-2
While both COX-1 and COX-2 convert arachidonic acid to prostaglandin, resulting
in pain and inflammation, their other functions make inhibition of COX-1
undesirable while inhibition of COX-2 is considered desirable.
COX-1:
COX-1 is a constitutive enzyme because it is produced by a cell under all types of
physiological conditions. The amount at which constitutive enzymes are produced
remain constant without regard of substrate concentration and physiological
demand.
Location:
COX-1 is commonly found in the kidney, stomach and platelets.
Function:
COX-1 play important role in housekeeping such as it protects gastric mucosa,
regulate gastric acid and maintain normal functions of kidney and platelet by
stimulating prostaglainds.
67
Maesha Musarrat (Lipids)
Production:
The stimulation of COX-1 enzyme is done on a continuous basis by the body.
Usefulness:
COX-1 enzymes are protective in nature and therefore are useful for the body. So
there is no need to inhibit them.
Inhibition:
Nonsteriodial antiinflammatory drugs inhibit COX-1.
68
Maesha Musarrat (Lipids)
COX-2:
COX-2 is an inducible enzyme as it is produced under certain specific conditions
like inflammation.
Location:
COX-2 is located in macrophages, leukocytes and fibroblasts.
Function:
COX-2 is involved in the synthesis of prostaglandins that causes pain and
inflammation in the body.
Production:
COX-2 enzyme remain absent at normal condition and produced only at the time
of need. The stimulation of COX-2 enzymes is dependent upon cytokines.
Usefulness:
COX-2 enzyme plays an important role in inflammation and pyrexia. So it is
desirous to inhibit COX-2 enzyme
Inhibition:
There are different types of drugs that are used to inhibit COX-2 enzyme including
Celecoxib, Nonsteriodial antiinflammatory drugs.
69
Maesha Musarrat (Lipids)
70
Maesha Musarrat (Lipids)
❖ Diets rich in Marine lipids: (2012)
Marine lipid oils are omega-3 fatty acids. They are derived from the body oils of
deep cold-water fish. They reduce the risk of atherosclerosis and cancer. Marine
Lipid Oils (Omega-3 Fatty Acids) prevent blood platelets from sticking together
(makes the blood less sticky); thins the blood and improves blood flow.
They lower bad cholesterol and triglycerides. They help prevent heart attacks and
strokes; lower blood pressure; enhance the immune system. They help prevent
depression; offer protection against migraines and kidney disease. They reduce
the signs and symptoms of psoriasis, eczema, and rheumatoid arthritis. Marine
lipid oils (omega-3 fatty acids) keep the skin, hair and nails healthy. The
mechanisms of decrease in cholesterol, prostaglandin and leukotriene level by
marine lipids are described below -
Decrease cholesterol level:
Diets rich in marine lipids are a good source of omega-3 fatty acids. Omega-3 fatty
acids are poly unsaturated fatty acids. They reduce the cholesterol level because
they help in the esterification of cholesterol present in high density lipoprotein
(HDL). Poly unsaturated fatty acid is invariably required for forming lecithin. Long
chain fatty acid tends to increase the cholesterol level. Short chain and medium
fatty acids neither decrease nor increase cholesterol level. Poly unsaturated fatty
acids increase high density lipoprotein (HDL) and decrease low density lipoprotein
(LDL). Omega-3 fatty acid inhibits the biosynthesis of very-low-density
lipoproteins (VLDL) and triglycerides in the liver.
Decrease prostaglandin levels:
Prostaglandins are 20-carbon hydroxyl fatty acids containing a five-membered
ring. These are widely distributed in lungs, kidney, thyroid, spleen, brain, iris,
endometrium etc. The prostaglandins PGE1 and PGE2 induce the symptoms of
inflammation (redness, swelling, edema etc.). Diets rich in marine lipids can
decrease prostaglandin level in the body.
71
Maesha Musarrat (Lipids)
Diets rich in marine lipids are a good source of omega-3 fatty acid. Omega-3 fatty
acid causes its prostaglandin-lowering effects through three different
mechanisms.
First, the much fewer prostaglandins are made from omega-3 fatty acids as
compared to the other class of fatty acids in the body, the omega-6 family of fatty
acids that originate in the diet from leafy vegetables and other plant sources.
Second, the omega-3 fatty acids compete with omega 6 fatty acids for the same
binding site on the COX-1 enzyme that converts the omega-6 fatty acids to
prostaglandin. The more omega-3 fatty acids present to block the binding sites,
the fewer omega 6 fatty acids are able to be converted to prostaglandin.
Third, although omega-3 fatty acids also are converted to prostaglandins, the
prostaglandins formed from omega-3 are generally 2 to 50 times less active than
those formed from the omega-6 fatty acids from dietary plants.
Decrease leukotrine level:
Excess production of leukotrienes promotes the inappropriate response to
harmless antigenic substances that characterizes allergy. Leukotrienes are fatty
acid-derived inflammatory mediators that play a significant role in the
pathophysiology of allergic diseases, including asthma, atopic dermatitis, and
allergic rhinitis. They are derived from the fatty acid arachidonic acid (AA), which
is concentrated in the membrane phospholipids of blood cells. They are
synthesized by circulating immune cells in response to a stimulus such as allergen
exposure.
72
Maesha Musarrat (Lipids)
Diets rich in marine lipids are a good source of omega-3 fatty acid.
Eicosapentaenoic acid (EPA), an omega-3 fatty acid, competes with arachidonic
acid (AA), an omega-6 fatty acid, for prostaglandin and leukotriene synthesis at
the cyclooxygenase and lipoxygenase level. When humans ingest diets rich in
marine oil, the omega-3 fatty acids; EPA and docosahexaenoic acid (DHA) from
marine oil lead to a decrease in leukotriene B4 formation an inducer of
inflammation by inhibiting the action of the 5-lipoxygenase enzyme (5-LO).
73
Maesha Musarrat (Lipids)
❖ Synthetic Lipid: (2013, 2012, 2010)
The lipids which are artificially produced in the laboratory are known as synthetic
lipids. Comparing with natural lipids, artificial lipids have higher level advantages.
These lipids are produced by the combination of sphingolipid and phospholipid.
Synthetic lipids are free from bacterial contamination. Recently, high quality fatty
acids specially poly unsaturated fatty acids are produced as synthetic lipids. Now,
artificial phospholipid having composition of various fatty acids are available
adequately.
Examples of synthetic lipid:
1) Lecithin/ Phosphatidyl choline
Product name: COTSOME MC – 100
Chemical name: 1,2-didecanoyl-glycero-3-phosphocholine (DDPC)
2) Phosphatidyl glycerol
Product name: COATSOME – 21LS
Chemical name: Hydrogenated Soyabean Phosphatidyl Glycerol Sodium salt
(HSPGS)
74
Maesha Musarrat (Lipids)
Synthetic Phospholipid derivatives:
Figure: Phosphotidylcholine
Figure: Phosphotidylglycerol
Figure: Phosphotidylamine
75
Maesha Musarrat (Lipids)
Figure: Phosphotidylacid
Functions of synthetic lipids:
1. Synthetic lipids produced from artificial components are very useful for lung
disorder patients.
2. Pulmonary surfactant decreases the surface tension of alveolar wall. In this way
protects the lungs from pollution after respiration.
Surfactant deficiency results lungs disorder. Generally infants are suffering from
this problem. The main components of the surfactant are Dipalmitoyl
Phosphatidyl Choline (DPC) and phosphatidyl glycerol.
3. They control delivery of drugs, vitamins and cosmetic materials.
4. They are used in increasing drug formulation in pharmaceuticals companies.
5. Synthetic lipids are used to design new drugs and cosmetics.
76
Maesha Musarrat (Lipids)
❖ The occurrence of main lipids in the human body: (2014)
Lipids are an important part of the body, along with proteins, sugars and minerals.
Lipids are important for cell membrane structure, regulating metabolism and
reproduction, the stress response, brain function and nutrition. Although excess
fat in the diet can lead to obesity, lack of lipids in the diet can lead to serious
problems, including blood clotting, bone structure and eyesight problems when
fat-soluble vitamins are not present in the diet. The occurrence of main lipids in
the human body are described below –
1. Cell membranes
The cell membrane is comprised of two layers of lipid. The long hydrophobic fatty
acid tails of phospholipids and glycolipids clump together in the interior of the
membrane and the hydrophilic head groups line the inner and outer sides of the
membrane. The membrane separates the inside of the cell from the outside, and
most molecules require a specific protein to help it cross the membrane.
2. Hormones
Cholesterol is modified into corticosteroids in the adrenal glands. Glucocorticoids
regulate the metabolism of sugars and the stress response. Mineralocorticoids
regulate the salt and water balance in the body. Cholesterol is also made into
androgens, like testosterone, and estrogens, which regulate reproduction and
secondary sexual characteristics (that make males look masculine and females
look feminine).
3. Fat-soluble vitamins
Sunlight helps the body turn cholesterol into Vitamin D, which regulates calcium
and phosphorus metabolism and is crucial for strong bones and teeth. Vitamin A
is required for retinol production and good eyesight. Vitamin K is required for
proper blood clotting. The antioxidant properties of Vitamin E help prevent and
repair cell damage.
77
Maesha Musarrat (Lipids)
4. Fat cells
Fat cells store concentrated dehydrated triacylglycerols as fat droplets in the
cytoplasm. After fasting (when you wake up in the morning) some fat is broken
down to fatty acids and released into the blood for use by other cells. Most
people have enough fat stored for about a month.
5. Brain
Brain cells have long axons and dendrites, and therefore a lot of cell membrane.
Sphingomyelin, a phospholipid, forms the myelin sheath that insulates nerve
axons, and helps increase the speed of nerve conduction.
6. Blood
Cholesterol in the blood is bound to high density and low density lipoproteins
(HLD and LDL). Steroid hormones also bind carrier proteins in the blood. Fatty
acids released from fat cells into the blood are available to all cells that need
energy.
❖ HDL is more important than VLDL: (2009)
HDL and VLDL are lipoproteins. Lipoproteins are molecular complexes that consist
of lipids and proteins (conjugated proteins). They function as transport vehicles
for lipids in blood plasma. Lipoproteins deliver the lipid components (cholesterol,
triacylglycerol etc.). There are five major classes of lipoproteins in human plasma.
They are chylomicrons, very low density lipoprotein (VLDL), intermediate density
lipoprotein (IDL), low density lipoprotein (LDL) and high density lipoprotein (HDL).
The liver releases VLDL into circulation. VLDL is made up of 55-65% triglycerides,
10-15% cholesterol, 15-20% phospholipid, and 5-10% protein. For comparison,
HDL the good holesterol is
-50% protein. Once the VLDL is released,
enzymes in the bloodstream interact with the triglycerides within the lipoprotein
a d ha ge the pa kage fro
er lo de sit to lo de sit . LDL is less
de se tha VLDL e ause it has lost a large hu k of trigl erides, ha gi g its
78
Maesha Musarrat (Lipids)
concentration to 10% triglycerides, 45% cholesterol, 22% phospholipid, and 25%
protein. Now, there is an intermediate step between the VLDL and LDL.
If LDL level becomes high, an oxidation process takes place that leads to plaque
development in artery walls, damage to vessel linings, and heart disease. LDL is
also k o as ad holesterol .
HDL act in a variety of helpful ways that tend to reduce the risk for heart disease.
It scavenges and removes LDL. HDL regulates the movement of cholesterol from
tissues to the liver for clearance. The process is called reverse cholesterol
transport. If the reverse cholesterol transport process is not functioning
efficiently, lipids can build up in tissues such as the arterial wall. Thus, reverse
cholesterol transport is essential for avoiding atherosclerosis. HDL reduces,
reuses, and recycles LDL cholesterol by transporting it to the liver where it can be
reprocessed. They also act as a maintenance crew for the inner walls
(endothelium) of blood vessels. Damage to the inner walls is the first step in the
process of atherosclerosis, which causes heart attacks and strokes. HDL scrubs the
wall clean and keeps it healthy. “o, HDL is k o as good holesterol .
Therefore, from the above discussion it can be concluded that HDL is more
important than VLDL.
79
Maesha Musarrat (Lipids)